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BACKGROUND: Adhatoda schimperiana is a plant believed to have several therapeutic effects 
including anti-asthmatic properties. The objective of this study was to investigate the bronchodialatory, 
anti-inflammatory effects and toxicity of the hydromethanolic extract of leaves of this plant.  
METHODS: The isolated guinea-pig trachea pre-contracted with histamine and acetylcholine was used 
to study the relaxation of hydromethanolic extract of leaves Adhatoda shimperiana. Salbutamol and 
atropine were used as standards. The effect of the hydromethanol extract of leaves of Adhatoda 
schimperiana on carageenin-induced acute inflammation was evaluated by the rat hind paw edema 
method. Oral and interaperitoneal acute toxicity studies of the extract were performed on mice.  
RESULTS: The hydromethanolic extract of Adhatoda schimperiana inhibited contractions of guinea 
pig tracheal chains induced by acetylcholine and histamine with an EC50 of 4.66 mg/ml and 5.92 mg/ml, 
respectively. Salbutamol and atropine also showed similar concentration dependent relaxation of the 
tracheal chains pre-contracted with both acetylcholine and histamine. The inhibitory activity of atropine 
was lower than the extract and salbutamol. The extract exhibited a moderate degree of anti-
inflammatory activity. The LD50 of the extract for oral acute toxicity study was found to be 1286.76 
mg/kg with 95 % confidence limit of 1161.9 – 1418.0. The plant extract therefore presents a relatively 
low acute toxicity.  
CONCLUSION: The results of this study show anti-inflammatory activity and a relatively potent 
relaxant (bronchodialatory) effect of Adhatoda schimperiana on the tracheal chain of the guinea pig. 
These activities justify the traditional use of this plant in the treatment of bronchoconstrictive diseases. 
More detailed studies are required to investigate the mechanism of action, the toxicity and the 
therapeutic utility of Adhatoda schimperiana for further development towards a proper drug. 
   




Bronchial asthma is a disease characterized by 
increased responsiveness of the trachea, bronchi 
and bronchioles to various stimuli and is manifested 
by wide spread narrowing of the airways in allergic 
asthma, bronchoconstriction and bronchial 
secretion are the results of an immediate 
hypersensitivity reaction (1). Bronchial asthma is 
one of the most disabling diseases, affecting nearly 
7-10% of world population (2).                                                                                                                                                                                                                                                                             
 Bronchoconstriction plays a very important 
role on the physiopathology of asthma and 
compounds that relax respiratory smooth muscles 
such as 2 -agonists and cholinergic antagonists are 
usually used in symptomatic treatments of the 
disease (3). Bronchodialotors help to stop asthma 
attacks after they have started or can help prevent 
recurrent attacks. The clinical management of acute 
asthma is with bronchodialators like 2 receptor 
agonists, antimuscarinics, and anti-inflammatory 
therapy with corticosteroids and administration of 
oxygen if necessary (2).   
 A number of bronchodialatory compounds 
from plant origin are being used for the treatment of 
asthma. Typical examples of these compounds are 
theophilline and ephedrine. Many medicinal plants 
including A. shimperiana have been documented as 
remedy for the treatment of asthma in the Ethiopian 
traditional medicine (4). A. shimperiana (Hochst) 
Nees Acanthaceae, Synonym Justicia shimperiana 
(Nees in DC) locally known as Sensel or Simiza 
(Amharic), Dhumuga (Oromifa) is a popular folk 
medicine, extensively used in the treatment of 
respiratory diseases such as asthma (4, 5). The plant 
is also reported to be a remedy for malaria and 
Leishmaniasis and has demonstrated activity 
against HIV 1 and 2 subtypes (5-7). A. shimperiana 
is commonly found in villages and towns growing 
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on wastelands, as a hedge or as live fences around 
native homesteads (8). Despite the widespread use 
of A. shimperiana by the Ethiopian population for 
the treatment of respiratory diseases, there is little 
information about its pharmacological properties. 
As the isolated guinea-pig trachea is a well-
accepted pharmacological model for the study of 
bronchospasmolytics, the effect of hydromethanolic 
extract of leaves A. shimperiana on guinea-pig 
respiratory smooth muscle was studied (9). The 
effect of the hydromethanol extract was also 
evaluated on carageenin-induced acute 
inflammation of the rat hind paw edema method 
and acute toxicity studies of the extract were 
investigated on mice.  
 
MATERIALS AND METHODS   
 
The leaves of A. schimperina were collected from 
Kebena, Addis Ababa, Ethiopia. Voucher 
specimens have been deposited at the Herbarium of 
Department Drug Research, Ethiopian Health and 
Nutrition Research Institute. Fresh dried leaves 
were macerated and extracted with methanol for 24 
hours at room temperature. The extracts were 
filtered and dried under reduced pressure at a 
temperature not higher than 40°C. The material 
obtained was divided in aliquots, which were stored 
at 40C until further use.  
 Acetycholine bromide (Riedl-de Haen 64241), 
Acetylsalicylsaeure (Bayer AG A3-05-6), Histamin 
dihydrochloride (Fulka, 53300) and Salbutamol 
phosphate BP [(Sal/007/2003), Harmesh 
Chemicals, Khandelwal Lab. Ltd. Dadha] were 
used and the other chemicals were from Sigma 
Chemical Co., St. Louis, USA. Extracts were either 
directly dissolved in Krebs solution or in distilled 
water. 
 Male guinea pigs weighing 250-350 gram and 
bred in the animal house of the Ethiopian Health 
and Nutrition Research Institute were used. The 
guinea pigs were killed by sharp head blowing and 
cutting the neck blood vessel. The trachea was 
gently and rapidly dissected and cut transversely 
between the segments of cartilage so as to give a 
number of rings of tracheal muscle. All fat and 
connective tissue were removed from the trachea. 
Six tracheal rings were tied together with cotton 
string so as to form a chain, and were mounted in 
an organ bath containing 20 ml of Krebs solution 
(composition in mM: NaCl 120, KCl 4.77, CaCl2 
25, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25, and 
glucose 11) which was maintained at pH 7.4, 37°C 
bubbled with 5%CO2 in oxygen (10,11). The 
tissues were allowed to equilibrate under a resting 
tension of 0.5 gram for 1 hour (12). The isotonic 
contractions were recorded on a slow moving 
smoked Kymograph paper using a frontal writing 
lever. 
 Tissues were contracted with acetylcholine 
(10
-5
M) or histamine (10
-5
M). Once the response to 
the contractile agents had reached a plateau (100% 
contraction), experimental tissues were incubated 
during 10 minutes with various doses of 
hydromethanolic extract of A. schimperiana, 
salbutamol, atropine, theophyline and ephedrine 
while control tissues were pre-incubated with 
vehicle (saline solution). 
Isometric contractions were measured by model 7E 
Polygraph Recorder (Grass Instrument Co., Quincy, 
USA) using an FT-l0 sensor (CB-Sciences, Dover, 
NH, USA) connected and processed by an ATH- 
260 BioAmplifier.  Responses to the test extract 
and standard drugs were expressed as percentages 
of the maximum relaxation of contracted tissues 
induced by acetylcholine or histamine. The EC50 
value (the effective concentration causing 50% of 
maximum relaxation) was derived from the 
resulting dose-response curves. Each experimental 
group consisted of four to six tracheal preparations.  
 The effect of the hydromethanol extract of 
A.schimperiana on carageenan-induced acute 
inflammation was evaluated by the rat hind paw 
edema method (13). Male rats weighing 100-150 
grams, divided into five groups (n=5) were 
pretreated with hydromethanol extract of A. 
schimperiana, standard drug, and distilled water 
(vehicle) 1 hour before receiving the injection of 
0.5ml of 2% carageenan in normal saline solution 
into the sub-plantar area of the right hind paw. 
Control animals received an equivalent volume of 
acetylsalicylic acid (200mg/kg) and vehicle. The 
volume of the paw was determined with a 
plethysmometer (model 7140, Ugo Basile, Italy), at 
1, 2, 3, and 4 hrs after carrageenan.  
 Oral and interaperitoneal acute toxicity studies 
of the extract were performed on mice (14). Albino 
mice of either sex weighing 20-25 grams were 
divided in to five groups (n=5 per group). Each 
group was treated with vehicle (distilled water) or 
various doses of the hydromethanol extract of A. 
schimperiana (30, 100, 300,  1000, 1500 mg/kg) 
intraperitoneally in single doses. Similar groups of 
mice were treated with vehicle or various doses of 
the hydromethanol extract of A. schimperiana 
orally in single dose. The animals were observed 
continuously for 6 hours with a gap of 30 minutes 
to determine various changes in the autonomic and 
behavioral responses. They were kept under further 
observation for a period of 48 hours for mortality 
(15).  




 All experiments were repeated at least three 
times. The results were expressed as means  SEM 
and were analyzed by ANOVA. P < 0.05 was used 




Acetylcholine and histamine induced a substantial 
contraction of the guinea pig tracheal chain at a 
concentration of 10-5 M and the tissue returned to 
the baseline after washout with Krebs solution.  
 The hydromethanol extract of A. schimperiana 
relaxed the contractions induced by acethylcholine 
and histamine in a dose dependent manner at 
concentrations of 0.8, 2, 4, 6 and 10 mg/ml giving 
an EC50 of 4.66 mg/ml and 5.92 mg/ml, respectively 
(Fig. 1 and 2). Salbutamol also showed a 
concentration dependent relaxation of the tracheal 
chains pre-contracted with both acetylcholine and 
histamine (Fig. 3 and 4). Similar dose-dependent 
relaxation was observed by atropine on tracheal 
chains pre-contracted by acetylcholine, the response 
is less potent compared with salbutamol (Fig. 5). 
Tracheal chains pre-contracted by acetylcholine 
were also observed to be inhibited by theophyline 




















Fig.1. Effect of the extract on acetylcholine induced contraction of the isolated guinea pig tracheal chains. 



















Fig.2. Effect of the extract on histamine induced contraction of the isolated guinea pig tracheal chains. 






























































Fig.3. Concentration dependent relaxation effect of salbutamol on acetylcholine pre-contracted isolated 
















Fig.4. Concentration dependent relaxation effect of salbutamol on histamine pre-contracted isolated guinea 






































































Fig.5. Concentration dependent relaxation effect of atropine on acetylcholine pre-contracted isolated 
guinea pig tracheal chains. Symbols represent the mean  S.E.M of n 3-5 preparation per group.  
 
Oral administration of the hydromethanol extract of 
A. shimperiana exhibited no visible sign of toxicity 
and mortality up to a dose of 1500 mg/kg 
bodyweight. However, a dose of 1750 mg/kg 
caused 100 % mortality when the extract was 
administered through the intraperitoneal route. 
Noticeable behavioral changes were observed after 
the lethal dose such as, depression (decrease in 
motor activity), decrease in respiratory rate, body 
tremor, lethargy, and pilocarpism. The acute 
median lethal dose (LD50) of the extract was found 
to be 1286.76 mg/kg with 95 % confidence limit of 
1161.9 – 1418.0. The plant extract therefore 



































































Anti-inflammatory activity was assessed in terms of 
decrease in the linear circumference of the treated 
rat paw relative to the value at zero time. 
Hydromethanolic extract of A. schimperiana 
showed a dose dependent anti-inflammatory 
activity at the three doses tested, 200mg/kg, 
400mg/kg and 800mg/kg. The paw edema was 
inhibited by 12.16 %, 14.83 % and 16.66 % 
respectively, four hours after carageenan injection 
(Fig.7 which was statistically insignificant (P 
>0.05). On the other hand Asprin at a dose of 
200mg/kg showed a significant reduction (P < 0.05) 
compared to the control with 38 .01 % edema 
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Fig 7.  Dose dependent effect of the extract on carrageenan–induced paw edema in rats. Symbols represent 




The extract of A. schimperiana inhibited 
contractions induced by histamine and 
acetylcholine. These agents are implicated in 
various ways in the pathogenesis of asthma. 
Histamine is the most implicated mediator in 
bronchoconsitriction that accompany asthma (16).  
 Acetylcholine on its own can cause 
bronchoconstriction by activating different 
cholinergic fibers secondary to the stimulation of 
the sub-epithelial afferent fibers by inflammatory 
mediators such as histamine (17). The results of this 
study indicated that the hydromethanolic extract of 
the leaves of A. schimperiana relax significantly the 
tracheal muscle strips pre-contracted by 
acetylcholine similar to the antagonists, salbutamol 
and atropine. The extract probably acts by blocking 
the muscarinic receptors. Acetylcholine binds with 
the muscarinic receptors for its agonistic action in 
smooth muscle, where as antagonists compete with 
acetylcholine for a common binding site on 
muscarinic receptor of guinea-pig ileum preparation 
(18). Moreover, the results show that the effect of 
the extract is reversible since it does not modify the 
effect of acetylcholine tested after washing the 
extract from the preparation indicating the 
reversibility of its receptor binding.  
 The ability of the hydromethanolic extract of 
A. schimperiana to inhibit the contractions induced 
by the bronchoconstrictors, acethycoline and 
histamine suggests a possible role in the treatment 
of asthma. The inhibition of histamine-
precontracted trachea by the hydromethanolic 
extract of A. schimperiana indicates the 
involvement of 2-agonists on the relaxation of the 
tissue. From these findings it can be assumed that 
more than one mechanism of actions could be 




involved in the relaxation of pre-contracted tissue 
by the hydromethanol extract of A. schimperiana. 
Furthermore, the relaxation of histamine pre-
contracted trachea by the A. schimperiana indicates 
their potency in ameliorating established asthma. 
Airway responsiveness in asthma is attributed in 
part to changes in autonomic regulation particularly 
increased parasympathetic activity (19).  
 Airway obstruction/bronchoconstriction or 
airway hyperresponsiveness in asthma are believed 
to be a direct consequence of airway wall 
inflammation (20,21). The hydromethanolic extract 
of A. schimperiana exhibited a moderate degree of 
anti-inflammatory activity. The component(s) 
inhibiting the contractions induced by acetylcholine 
and histamine seem to be highly polar in nature 
since they were extracted by water-methanol, a very 
potent polar medium.  
 Mechanisms that possibly underlie this anti-
inflammatory activity include inhibition of the 
actions of inflammatory mediators such as 
histamine, effect on adernocorticoid hormone and 
immunosuppression. Inhibition of 
immunosuppression also incorporates inhibition of 
the activity of proinflammatory mediators. This 
proposed mechanism is consistent with previous 
findings that anti-inflammatory plant principles 
have shown to act through control of 
adrenocorticoid hormone and immunosuppression, 
respectively (22,23).  
Inherent anti-inflammatory activity is a desirable 
property of a putative anti-asthmatic agent, since 
asthma is a complex chronic inflammatory disease 
of the airways. The fact that the hydromethanol 
extract of A. schimperiana showed the anti-
inflammatory activity may justify the local 
extracting method of macerating the leaves in local 
beer which is mainly ethanol.  
 Sequel to the above, it is apparent that the 
mechanism of anti-asthmatic property of the leaf 
extracts of A. schimperiana is multifaceted: 
inhibition of spasmogens and immunosuppression 
may be involved. The bioactive component(s) 
responsible for the observed activities is not 
precisely known but it may be one or more of the 
phytochemical constituents established to be 
present in the leaf extracts. The potential 
application of other Adhatoda species for treatment 
of asthma has been reported; Adhatoda vasica is 
used for the treatment of asthma in Indian 
Ayurveda (the plant contains the alkaloids, 
vasicine, vasicinol and vasicinone, which illicit 
bronchodialating effect) (24,25). 
In the acute toxicity study of the methanol extract 
of leaves of A. schimperiana no deaths and no other 
signs of toxicity was observed at up to the highest 
dose tested (1500 mg/kg bodyweight) when 
administered orally. Since the extract had shown to 
be pharmacologically active, one can conclude that 
the active substances(s) presents rather low acute 
toxicity. Taking into account that the ED50 value 
and that no deaths were observed up to 750 mg/kg 
body weight, the safety margin (ALD/ED50) seems 
to be wide (>276.13 and 217.35) for the extract. 
Besides the fact that ALD values following 
intraperitoneal administration were high, where 
human exposure to hydromethanolic extracts of A. 
schimperiana leaves is very unlikely to occur.  
 The results of this study showed anti-
inflammatory activity, a relatively potent relaxant 
(bronchodialatory) effect of A.schimperiana on the 
tracheal chain of the guinea pig and low toxicity. 
These activities justify the traditional use of this 
plant in the treatment of bronchoconstrictive 
diseases. Detailed investigation of the efficacy, 
isolation of the active ingridient and further toxicity 
study may warrant the development of the plant 
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